Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
BMC Pediatrics
Published in: BMC Pediatrics 1/2017

Open Access 01-12-2017 | Research article

Utilization of ultrasonography to detect developmental dysplasia of the hip: when reality turns selective screening into universal use

Authors: Rachel Wilf–Miron, Jacob Kuint, Ronit Peled, Asaf Cohen, Avi Porath

Published in: BMC Pediatrics | Issue 1/2017

Login to get access

Abstract

Background

Developmental dysplasia of the hip (DDH) occurs in 3–5 of 1000 live births and is associated with known risk factors. In most countries, formal practice for early detection of DDH entails the combination of risk factor identification and physical examination of the hip, while the golden standard diagnostic instrument is hip ultrasonography (US). This practice is commonly referred to as selective screening. Infants with positive US findings are treated with a Pavlik harness, a dynamic abduction splint.
The objective of our study was to evaluate hip US utilization patterns in Maccabi Healthcare Services (MHS), a large health plan.

Methods

Study population: All MHS members, born between June 2011 and October 2014, who underwent at least one US before the age of 15 months. Study variables: Practice specialty and number of enrolled infants. Positive US result was defined as referral to an abduction splint. Cost was based on Ministry of Health price list. Chi square and correlation coefficients were employed in the statistical analysis.

Results

Of the 115,918 infants born during the study period, 67,491 underwent at least one hip US. Of these, 60.6% were female, mean age at performance: 2.2 months. Of those who underwent US, 625 (0.93%) were treated with a Pavlik harness: 0.24% of the male infants and 1.60% of the female infants (p < 0.001). Analysis of physician practice characteristics revealed that referral to US was significantly higher among pediatricians as compared with general practitioners (60% and 35%, respectively). Practice volume had no influence on referral rate. Direct medical costs of the 107 hip US examinations performed that led to detection of one positive case (treated by Pavlik): US$10,000.

Conclusions

Current pattern of hip US utilization for early detection of DDH resembles universal screening more closely than selective screening. This can inform policy decisions as to whether a stricter selective screening or a formal move to universal screening is appropriate in Israel.
Literature
1.
Sewell MD, Rosendahl K, Eastwood DM. Clinical Review: Developmental dysplasia of the hip. BMJ. 2009;339:b4454.CrossRefPubMed
2.
3.
Bialik V, Bialik GM, Blazer S, Sujov P, Wiener F, Berant MSO. Developmental dysplasia of the hip: a new approach to incidence. Pediatrics. 1999;103(1):93.CrossRefPubMed
4.
Ortiz-Neira CL, Paolucci EO, Donnon T. A meta-analysis of common risk factors associated with the diagnosis of developmental dysplasia of the hip in newborns. Eur J Radiol. 2012;81(3):e344–51.CrossRefPubMed
5.
Committee SMA. Screening for the detection of congenital dislocation of the hip. Arch Dis Child. 1986;61:921–6.CrossRef
6.
Shipman SA, Helfand M, Moyer VA, Yawn BP. Screening for developmental dysplasia of the hip: a systematic literature review for the US preventive services task force. Pediatrics. 2006;117:e557–76.CrossRefPubMed
7.
Sanghrajka A, Murnaghan CF, Shekkeris A, Eastwood DM. Open reduction for developmental dysplasia of the hip: failures of screening or failures of treatment? Ann R Coll Surg Engl. 2013;95(2):113–7.CrossRefPubMedPubMedCentral
8.
Sink EL, Ricciardi BF, Torre KD, Price CT. Selective ultrasound screening is inadequate to identify patients who present with symptomatic adult acetabular dysplasia. J Child Orthop. 2014;8(6):451–5.CrossRefPubMedPubMedCentral
9.
Americal Academy of Pediatrics. Clinical practice guideline: early detection of developmental dysplasia of the hip. Pediatrics. 2000;105(4):896-905.
10.
Rosenberg N, Bialik V, Norman D, Blazer S. The importance of combined clinical and sonographic examination of instability of the neonatal hip. Int Orthop. 1998;22(3):185–8.CrossRefPubMedPubMedCentral
11.
Choudry Q, Goyal R, Paton RW. Is limitation of hip abduction a useful clinical sign in the diagnosis of developmental dysplasia of the hip? Arch Dis Child. 2013;98(11):862–6.CrossRefPubMed
12.
13.
Eidelman M, Katzman A, Freiman S, Peled E, Bialik V. Treatment of true developmental dysplasia of the hip using Pavlik's method. J Pediatr Orthop B. 2003;12(4):253–8.PubMed
14.
Elbourne D, Dezateux C, Arthur R, Clarke NM, Gray A, King A, Quinn A, Gardner F, Russell G. UK collaborative hip trial group. Ultrasonography in the diagnosis and management of developmental hip dysplasia (UK hip trial): clinical and economic results of a multicentre randomised controlled trial. Lancet. 2002;360(9350):2009–17.CrossRefPubMed
15.
Peled E, Bialik V, Katzman A, Eidelman M, Norman D. Treatment of Graf’s ultrasound class III and IV hips using Pavlik’s method. Clin Orthop Relat Res. 2008;466(4):825–9.CrossRefPubMedPubMedCentral
16.
17.
Mahan ST, Katz JN, Kim YJ. To screen or not to screen? A decision analysis of the utility of screening for developmental dysplasia of the hip. J Bone Joint Surg. 2009;91(7):1705–19.CrossRefPubMedPubMedCentral
18.
Cashman JP, Round J, Taylor G, Clarke NM. The natural history of developmental dysplasia of the hip after early supervised treatment in the Pavlik harness. Bone Joint J. 2002;84(3):418–25.CrossRef
19.
Tiruveedhula M, Reading IC, Clarke NMP. Failed Pavlik harness treatment for DDH as a risk factor for avascular necrosis. J Pediatr Orthop. 2015;35(2):140–3.CrossRefPubMed
20.
21.
Morin C, Wicart P. And French Society of Pediatric Orthopaedics. Congenital dislocation of the hip, with late diagnosis after 1year of age: update and management. Orthop Traumatol Surg Res. 2012;98(6):S154–8.CrossRefPubMed
22.
Holen KJ, Tegnander A, Bredland T, Johansen OJ, Sæther OD, Eik-Nes SH, Terjesen T. Universal or selective screening of the neonatal hip using ultrasound? A prospective, randomized trial of 15,529 newborn infants. Bone Joint J. 2002;84(6):886–90.CrossRef
23.
Gray A, Elbourne D, Dezateux C, King A, Quinn A, Gardner F. Economic evaluation of ultrasonography in the diagnosis and management of developmental hip dysplasia in the United Kingdom and Ireland. J Bone Joint Surg Am. 2005;87(11):2472–9.PubMed
24.
Shorter D, Hong T, Osborn DA. Cochrane review: screening programmes for developmental dysplasia of the hip in newborn infants. Evid Based Child Health. 2013;8(1):11–54.CrossRefPubMed
25.
Tabenkin H, Lahad A. The Israeli task force on health promotion and preventive medicine: Clinical guidelines. The Israel Association of Family Physicians and the Israeli Medical Association. 2013. (First publication - 2000; revised in 2004, 2008 and 2013). (in Hebrew).
26.
Dor M. Identification of hip joint instability in neonates and infants. Instructions of the Ministry of Health, based on the recommendation of the National Council on Pediatrics and Child Health, 2014, Jerusalem. Also available at http://​www.​health.​gov.​il/​hozer/​mr17_​2007.​pdf. Accessed 17 Mar 2017. (in Hebrew).
27.
Laborie LB, Markestad TJ, Davidsen H, Brurås KR, Aukland SM, Bjørlykke JA, Reigstad H, Indrekvam K, Lehmann TG, Engesæter IØ, et al. Selective ultrasound screening for developmental hip dysplasia: Effect on management and late detected cases. A prospective survey during 1991-2006. Pediatr Radiol. 2014;44(4):410–24.CrossRefPubMed
28.
Clarke NM, Reading IC, Corbin C, Taylor CC, Bochmann T. Twenty years' experience of selective secondary ultrasound screening for congenital dislocation of the hip. Arch Dis Child. 2012;97(5):423–9.CrossRefPubMed
29.
McAbee GN, Donn SM, Mendelson RA, McDonnell WM, Gonzalez JL, Ake JK. Medical diagnoses commonly associated with pediatric malpractice lawsuits in the United States. Pediatrics. 2008;122(6):e1282–6.CrossRefPubMed
Metadata
Title
Utilization of ultrasonography to detect developmental dysplasia of the hip: when reality turns selective screening into universal use
Authors
Rachel Wilf–Miron
Jacob Kuint
Ronit Peled
Asaf Cohen
Avi Porath
Publication date
01-12-2017
Publisher
BioMed Central
Published in
BMC Pediatrics / Issue 1/2017
Electronic ISSN: 1471-2431
DOI
https://doi.org/10.1186/s12887-017-0882-0

Other articles of this Issue 1/2017

BMC Pediatrics 1/2017 Go to the issue

Research article

School-time physical activity among Arab elementary school children in Qatar

Research article

Early dynamic ultrasound for neonatal hip instability: implications for rural Australia

Research article

Improving feeding and growth of HIV-positive children through nutrition training of frontline health workers in Tanga, Tanzania

Research article

Urinary Neutrophil Gelatinase-associated Lipocalin in the evaluation of Patent Ductus Arteriosus and AKI in Very Preterm Neonates: a cohort study

Research article

Causes of death in very preterm infants cared for in neonatal intensive care units: a population-based retrospective cohort study

Research article

Congenital malformations and medical conditions associated with orofacial clefts in children in Burkina Faso